Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Current Leases (2021 - 2025)

Historic Current Leases for InMed Pharmaceuticals (INM) over the last 5 years, with Q3 2025 value amounting to $424765.0.

  • InMed Pharmaceuticals' Current Leases rose 11.9% to $424765.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $424765.0, marking a year-over-year increase of 11.9%. This contributed to the annual value of $435507.0 for FY2025, which is 3703.94% up from last year.
  • Latest data reveals that InMed Pharmaceuticals reported Current Leases of $424765.0 as of Q3 2025, which was up 11.9% from $435507.0 recorded in Q2 2025.
  • In the past 5 years, InMed Pharmaceuticals' Current Leases registered a high of $435507.0 during Q2 2025, and its lowest value of $82232.0 during Q3 2021.
  • In the last 5 years, InMed Pharmaceuticals' Current Leases had a median value of $404163.0 in 2022 and averaged $373529.1.
  • Per our database at Business Quant, InMed Pharmaceuticals' Current Leases soared by 39149.11% in 2022 and then crashed by 2750.5% in 2023.
  • InMed Pharmaceuticals' Current Leases (Quarter) stood at $391805.0 in 2021, then rose by 5.74% to $414307.0 in 2022, then decreased by 12.1% to $364190.0 in 2023, then rose by 15.25% to $419711.0 in 2024, then grew by 1.2% to $424765.0 in 2025.
  • Its Current Leases was $424765.0 in Q3 2025, compared to $435507.0 in Q2 2025 and $429247.0 in Q1 2025.